Novartis Institutes for BioMedical Research, Inc. 4
4 · Homology Medicines, Inc. · Filed Apr 4, 2018
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2018-04-02+1,979,226→ 1,979,226 total - Conversion
Series B Preferred Stock
2018-04-02−1,979,226→ 0 total→ Common Stock (1,979,226 underlying)
Footnotes (2)
- [F1]The securities reported herein are held of record by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG. Novartis AG may therefore be deemed to have or share beneficial ownership of the Common Stock held directly by NIBRI.
- [F2]Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock.